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Abstract
Mutation rates can evolve through genetic drift, indirect selection due to genetic hitchhiking, 
or direct selection on the physicochemical cost of high fidelity. However, for many systems, 
it has been difficult to disentangle the relative impact of these forces empirically. In RNA 
viruses, an observed correlation between mutation rate and virulence has led many to argue 
that their extremely high mutation rates are advantageous because they may allow for 
increased adaptability. This argument has profound implications because it suggests that 
pathogenesis in many viral infections depends on rare or de novo mutations. Here, we pres-
ent data for an alternative model whereby RNA viruses evolve high mutation rates as a 
byproduct of selection for increased replicative speed. We find that a poliovirus antimutator, 
3DG64S, has a significant replication defect and that wild-type (WT) and 3DG64S populations 
have similar adaptability in 2 distinct cellular environments. Experimental evolution of
3DG64S under selection for replicative speed led to reversion and compensation of the fidel-
ity phenotype. Mice infected with 3DG64S exhibited delayed morbidity at doses well above 
the lethal level, consistent with attenuation by slower growth as opposed to reduced muta-
tional supply. Furthermore, compensation of the 3DG64S growth defect restored virulence, 
while compensation of the fidelity phenotype did not. Our data are consistent with the kinetic 
proofreading model for biosynthetic reactions and suggest that speed is more important 
than accuracy. In contrast with what has been suggested for many RNA viruses, we find 
that within-host spread is associated with viral replicative speed and not standing genetic 
diversity.
Author summary
Why organisms have different mutation rates is a longstanding question in evolutionary
biology. The polymerases of RNA viruses generally lack proofreading activity and exhibit
extremely high mutation rates. Because most mutations are deleterious and mutation
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rates are typically tuned by natural selection, we asked why RNA viruses haven’t evolved
a polymerase with a lower mutation rate. We used experimental evolution and a murine
infection model to show that RNA virus mutation rates may actually be too high and are
not necessarily adaptive. Rather, our data indicate that viral mutation rates have evolved
to be higher as a result of selection for viruses with faster replication kinetics. We suggest
that viruses have high mutation rates, not because they facilitate adaptation but because
it is hard to be both fast and accurate and these viruses have prioritized speed over
fidelity.
Introduction
Mutation is the ultimate source of genetic variation, and mutation rates can have a significant
impact on evolutionary rate [1–3]. The intraspecific variability in mutation rate in many
viruses and bacteria indicates that mutation rates have been optimized by natural selection [4–
13]. Given that most mutations are deleterious, the burden of excess mutational load will select
against strains with abnormally high mutation rates [14–17]. This principle led Sturtevant to
ask, “Why does the mutation rate not evolve to zero?” [18,19].
A large body of theoretical and experimental work suggests that the selective pressure for
higher mutation rates is due to either the physicochemical cost of maintaining a lower one or a
selective advantage from an increased supply of beneficial mutations [20–23]. Many have
argued for the adaptive benefit of high mutation rates in pathogenic microbes, which often
exist in dynamic environments and are subject to host immune pressure [7,24,25]. However,
direct selection of a variant with a higher mutation rate will only occur if it has been advanta-
geous in the past, and in many cases, it has been difficult to separate the causes of a higher
mutation rate from its consequences [19,26].
RNA viruses are ideal systems for studying the selective forces that act on mutation rates.
While interspecies mutation rates range from 10−4 to 10−6 errors per nucleotide copied [4],
studies of antimutators and hypermutators suggests that fidelity can only vary by several-fold
within a species [27]. The severe burden of mutational load exerts a strong downward pressure
on mutation rates, and hypermutator strains are attenuated in vivo [9,28–31]. Given the short
generation times and remarkable fecundity of many RNA viruses, a small kinetic cost to higher
fidelity should result in strong selection against antimutators [32,33]. However, the observed
attenuation of antimutator RNA viruses in vivo has led many to argue for the adaptive benefit
of high mutation rates, as genetic diversity provides a rich substrate for a virus’s evolution in
the face of varying intrahost environments [7,10,34–38]. This concept is central to viral quasis-
pecies theory, which generally proposes a link between genetic diversity and viral fitness
[24,25].
Here, we define the selective forces that shape viral mutation rates by studying an antimuta-
tor variant. The 3DG64S mutant of poliovirus was selected after serial passage in ribavirin, an
RNA virus mutagen. The RNA-dependent RNA polymerase (RdRp, 3D) of this variant con-
tains a single glycine to serine substitution [5–7]. The basal mutation rate of 3DG64S is reported
to be approximately 20% to 30% that of wild-type (WT) virus. While the 3DG64S mutant is
attenuated in poliovirus receptor (PVR) transgenic mice, the relative importance of replicative
speed and fidelity to this phenotype is not clear [7,36]. Biochemical assays of 3DG64S suggest a
physicochemical cost of high fidelity, but as in other systems, its contribution to overall fitness
remains unquantified [6,19,39].
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Results
We measured the relative fitness of 3DG64S by direct competition over serial passage by quanti-
tative reverse transcription polymerase chain reaction (qRT-PCR) (Fig 1A). Here, the fitness
of 3DG64S is 0.78 ± 0.01 (n = 3 replicates) relative to WT. This is a moderate fitness defect, fall-
ing in the 64th percentile in a dataset of 8,970 fitness values obtained for point mutants of
poliovirus under similar conditions [16] (e.g., human epithelial cells [HeLa] multiplicity of
infection [MOI] 0.1, 8-hour infection cycle, and 6 passages; Fig 1B). We also measured the rel-
ative growth properties of WT and 3DG64S using a plaque-size assay, which measures the
growth, burst size, and spread of individual viruses in the absence of competition [40–42]. The
distribution of clonal plaque sizes was significantly different (p< 0.005; unpaired t test with
Welch correction; n = 272 WT and n = 220 3DG64S plaques) and consistent with a moderate
fitness defect in 3DG64S (Fig 1C). In contrast with prior work, we were able to detect a signifi-
cant replication defect for 3DG64S by one-step growth curve, but only with rigorous synchroni-
zation, more frequent time points, and larger numbers of replicates (Fig 1D). This replication
defect was not specific to HeLa because we observed a similar lag for 3DG64S in a 3T3 cell line
Fig 1. A speed–fidelity trade-off in the poliovirus RdRp. (A) Relative fitness of 3DG64S as measured by direct competition. The amount of each virus
at each passage was compared to the input and expressed as the difference in the log10 ratio in RNA genomes for 3D
G64S (open circles) relative to WT
over time. The slope of the dotted lines are the relative fitness values, 0.78 ± 0.01, n = 3 replicates. (B) Cumulative distribution function of fitness values
for SNVs of poliovirus as determined in [16]. “” indicates the relative fitness (0.78) and percentile (64th) of 3DG64S. (C) Plaque size of clones from WT
(n = 272; black) and 3DG64S (n = 220; grey) virus populations. Box plots show median, 25% and 75% quartiles, and 1.5× interquartile range.
p 0.005; t test with Welch’s correction. (D) Single-cycle growth curve for WT (filled circles, black line) and 3DG64S (open circles, grey line) in
HeLa. Data are mean ± standard deviation (n = 5 replicates). p< 0.005; unpaired t test comparing WT and 3DG64S separately for each time point. (E)
Single-cycle growth curve for WT (filled circles, black line) and 3DG64S (open circles, grey line) in 3T3 cell line derived from MEFs of PVR transgenic
mice. Data are mean ± standard deviation (n = 5 replicates). p< 0.01; p< 0.005; unpaired t test comparing WT and 3DG64S separately for each
time point. (F) Relative fitness of 3DG64S (open circles) as measured by competition assay (see panel A) in the presence of varying concentrations of
ribavirin. Note that the baseline relative fitness of 3DG64S (y-intercept) is lower than the fitness reported in panel A because the assays were performed
under different experimental conditions (see Methods). (G) Mutation rate in mutations per nucleotide per strand copied for WT (filled circles) and
3DG64S (open circles) in the presence of varying concentrations of ribavirin, as determined by Luria Delbruck fluctuation test. All plotted data can be
found in S1 Data. HeLa, human epithelial cells; MEF, mouse embryonic fibroblast; PVR, poliovirus receptor; RdRp, RNA-dependent RNA polymerase;
SNV, single-nucleotide variant; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2006459.g001
that we derived from mouse embryonic fibroblasts (MEFs) from PVR mice (Fig 1E). These
data demonstrate that the fitness defect of 3DG64S is largely attributable to its slower replicative
kinetics and is consistent with biochemical assays on purified RdRp [6,39].
The reduced mutation rate and replicative fitness of 3DG64S suggest a trade-off between
speed and fidelity in RNA virus replication. Here, the fitness gain from increased replicative
speed is offset by a reduction in fitness due to increased mutational load. We derived a quanti-
tative model of this trade-off (see S1 Text Model 1) by measuring the replicative fitness (Fig
1F) and mutation rate (Fig 1G, S1 Table) of WT and 3DG64S under exposure to an exogenous
mutagen, ribavirin [43]. WT and 3DG64S had equal fitness at approximately 150 μM ribavirin.
Based on these data, our model indicates that WT incurs a fitness cost of 0.137 from muta-
tional load alone. Therefore, any fitness benefit of the high baseline mutation rates in WT
would presumably need to offset this cost. In 3DG64S, the cost of mutational load is reduced to
0.037.
If viral RdRp are constrained by a speed–fidelity trade-off, selection for increased replicative
speed (r-selection) will increase mutation rate. We subjected the 3DG64S-1nt point mutant
(A6176G) to r-selection over serial passage by infecting cells at low multiplicity and harvesting
progeny at 4.5 hours (midexponential phase of replication). The 3DG64S point mutant reverted
to WT within 15 passages in 5 independent lineages (Fig 2A). We only observed partial rever-
sion at passage 15 in a subset of 24-hour control lineages, in which virus populations under-
went twice as many cellular infection cycles per passage and experienced reduced r-selection.
We next asked whether r-selection would lead to genetic compensation of the fidelity pheno-
type in 3DG64S-3nt, which has all 3 positions in the codon mutated to minimize reversion. After
50 passages of r-selection, we identified fixed and polymorphic single-nucleotide variants
(SNVs) by next-generation sequencing of all r-selected and control (24-hour passage) popula-
tions of 3DG64S and WT (Fig 2B).
Unbiased hierarchical clustering of SNVs by type and frequency indicates that the viruses
explored distinct mutational pathways in adapting to either r-selective or control passaging
regimes. Within the r-selected group, WT and 3DG64S lineages clustered together, and we
noted a larger number of SNVs within the coding region for the RdRp across the 5 3DG64S
populations. We found that a number of distinct SNVs increased viral fitness when introduced
into the ancestral WT backbone. For example, the WT-VP4S22G had a fitness of 2.62, and its
presence in all r-selected and control lineages suggests that it mediates adaptation to HeLa
cells (see SI, S1 Data 2C). In contrast, a mutation in the viral helicase found only in r-selected
populations—2CV127L (fitness 1.41–1.67 in WT and 1.11 ± 0.02 in 3DG64S, SI S1 Data 2C)—
would be more likely to have a general effect on replicative speed.
To identify compensatory mutations, we focused our subsequent analysis on nonsynon-
ymous mutations in the RdRp that were found predominantly in r-selected populations,
shared among multiple lineages, and more frequent in 3DG64S than in WT. Two mutations—
U6261C/3DI92T and A6813G/3DK276R—met these criteria, and their frequencies at passages 30
and 50 suggest that the I92T mutation may have arisen first. The 3DI92T mutation, which was
found in both r-selected WT (3 out of 5) and 3DG64S (5 out of 5) lineages, did not change either
fitness or mutation rate appreciably in the 3DG64S background (Fig 2C and 2D). The r-selected
K276R substitution, which was found in 3DG64S lineages (4 out of 5) and not in WT popula-
tions, decreased overall fitness in both WT (0.92 ± 0.03; p = 0.0031 versus WT; t test) and
3DG64S (0.55 ± 0.03; p = 0.005 versus 3DG64S; t test). It had no detectable effect on mutation
rate in either background. The G64S/I92T/K276R triple mutant had a significant increase in
fitness (0.7637; p = 0.0012 versus 3DG64S; t test) and mutation rate (8.71 × 10−6 s/n/r;
p = 0.0120 versus 3DG64S; t test) compared to 3DG64S and each double mutant. Therefore,
direct selection for replicative speed led to indirect selection of mutations that together
Fig 2. R-selection leads to increased mutation rates. (A) A point mutant of 3DG64S (GGTgly to AGTser) was
introduced into a poliovirus genome that is marked with a nearby point mutation that ablates an AccI restriction site.
Viruses were serially passaged every 4.5 hours (r-selected) or every 24 hours (control) for 15 passages. Chromatograms
show the codon for position 64 (either GGTgly or AGTser). Gel image of AccI restriction digest of all passage 15
populations showing that the reversion occurred in the parental backbone and was not due to contamination with WT
virus, which retains the AccI site. (B) WT and a “locked in” version of 3DG64S (GGTgly to UCAser) were subjected to r-
selection (3.5–4 hours and 4–4.5 hours, respectively) or control (24-hour) passages for 50 passages as described in the
text. Heatmap shows all mutations identified at>0.025 frequency in2 out of the 20 total lineages, colored by log
frequency. Diagram at left shows regions of the poliovirus genome. (C) Fitness of indicated variants relative to WT as
determined by competition assay. Each symbol is a replicate competition assay, and exact p-values for the key
comparisons are provided in the main text. (D) Mutation rate of indicated variants in mutations per nucleotide per
strand copied as determined by Luria Delbruck fluctuation test. Each symbol is a replicate fluctuation test, and exact p-
values for the key comparisons are provided in the main text. (E) In vitro kinetics of purified RdRp. Purified RdRp
(2 μM), primer template (1 μM), and ATP were incubated, and samples were quenched at the indicated time points
(schematic). The kinetics of complex assembly and single-nucleotide incorporation are expressed as μM extended
template (y-axis) over time (x-axis). Representative data are shown. Complete data from replicates can be found in S1
Data 2E. All plotted data can be found in S1 Data. RdRp, RNA-dependent RNA polymerase; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2006459.g002
increase the poliovirus mutation rate, with sign epistasis among G64S, I92T, and K276R in the
RdRp.
To gain mechanistic insight into the interactions among these 3 mutations, we analyzed the
kinetics of single-nucleotide incorporation and misincorporation by purified RdRp. The
3DG64S;I92T RdRp exhibits an assembly defect relative to 3DI92T when incubated with purified
primer template and ATP (Fig 2E and [6]). The K276R mutation partially compensates for this
assembly defect in the 3DG64S;I92T background, resulting in a 1.5- to 2-fold increase in incorpo-
ration of the correct nucleotide (A opposite U). This interaction is dependent on G64S because
K276R reduced RdRp activity in the 3DI92T background. While some poliovirus mutators
exhibit altered kinetics of nucleotide misincorporation for G opposite U [30], the kinetics of
3DG64S;I92T;K276R were similar to those of 3DG64S;I92T (S1 Fig).
We further examined the relationship between RdRp speed and fidelity using a second
poliovirus antimutator. The 3DK359R RdRp has slower polymerization kinetics and higher
fidelity relative to WT, and the 3DK359H RdRp has similar characteristics [44]. In 2 separate
experiments, we infected HeLa cells with 3DK359H virus and recovered mutants after 1 or 2
passages. We observed 2 missense mutations in the 3D gene. Amino acid changes I331F and
P356H were identified together in 1 experiment, and the P356H change was identified alone in
the second. We introduced each of these amino acid substitutions alone or in combination
into the 3DK359H RdRp. In all cases, we observed an increase in the elongation rate (kpol) of
the viral polymerase (a surrogate for speed) as well as the nucleotide misincorporation rate
(kobs misincorporation for mutant relative to WT) in vitro (Table 1).
The adaptability of WT and high-fidelity viruses have generally been compared using assays
that measure the acquisition of drug resistance, the reversion of an attenuating point mutation,
or escape from microRNA in a limited number of replication cycles [5–7,34,36]. In these
experiments, mutations come at little cost, and the assays essentially quantify the beneficial
mutation rate. To capture better the impact of both deleterious and beneficial mutations on
adaptability, we measured the fitness gain of WT and 3DG64S over 20 passages in HeLa. While
our WT strain is “culture-adapted,” we found that it was far from a fitness peak; both WT and
3DG64S increased their fitness 10-fold in approximately 40 cellular infection cycles (20 pas-
sages, Fig 3A, S2 Fig). The difference in the rate of fitness gain between WT and 3DG64S line-
ages was small but statistically significant (0.025 per passage, WT > 3DG64S; mixed linear
effects model, p = 0.0129).
We examined adaptation to a completely distinct environment by repeating the experiment
on our PVR-3T3 cell line [45,46]. In this alternative species and cell type, we actually observed
greater fitness gain in the high-fidelity 3DG64S variant relative to WT (0.121 per passage; mixed
Table 1. Kinetic parameters for nucleotide incorporation and misincorporation for purified RdRp. The kpol for the correct nucleotide measures the speed of polymer-
ization in vitro. The kpol,corr/kpol,incorr is an in vitro surrogate for fidelity, as it measures the relative rates of incorporation for the correct and incorrect nucleotides. A higher
ratio indicates higher fidelity.
RdRp Correct Nucleotide Incorrect Nucleotide
kpol (s
−1) Kd,app (μM) kpol (s−1) [× 10−3]a kpol,corr/kpol,incorr
WT 37 ± 3 180 ± 40 4.2 ± 0.6 8,800
K359H 4.0 ± 0.2 250 ± 20 0.10 ± 0.02 40,000
I331F K359H 8.5 ± 0.1 170 ± 10 0.74 ± 0.13 11,000
P356S K359H 9.8 ± 0.3 110 ± 10 0.78 ± 0.09 13,000
I331F P356S K359H 17 ± 1 120 ± 10 4.9 ± 0.8 3,500
aDetermined at saturating concentrations of nucleotide substrate.
Abbreviations: RdRp, RNA-dependent RNA polymerase; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2006459.t001
linear effects model, p = 0.0013). The larger fitness gain in 3T3 cells may reflect a larger supply
of beneficial, compensatory mutations given the lower baseline fitness of 3DG64S in these cells.
These data suggest that, despite its 2-fold reduction in mutation rate, 3DG64S is not mutation
limited and that, in the absence of strong selection, any adaptive benefit of a higher mutation
rate is countered by the fitness cost of increased mutational load (see Fig 1F and 1G and associ-
ated model above).
We next compared the phenotype of WT and 3DG64S viruses in vivo, where the ability to
generate genetic diversity may allow a virus to escape host immune restriction and to repli-
cate better in a range of environments. The available data have suggested that the attenuation
of 3DG64S and other high-fidelity variants in experimental models is attributable to differ-
ences in the genetic diversity of the infecting population [7]. In this earlier work, viral
Fig 3. Adaptability of WT and 3DG64S over 20 passages in HeLa (A) or 12 passages in a 3T3 cell line derived from
mice transgenic for the PVR (B). Fitness values (3 replicate competition assays for each data point) were
determined for populations from every fifth passage (panel A) or every fourth passage (panel B), and the adaptability in
the top panels was expressed as the slope of the regression for log10 fitness over time for each of 5 independent lineages
of WT (filled circles) and 3DG64S (open circles, blue) for each cell line. The bottom panels show all the data from the 5
lineages together with the regression of log10 fitness over time. Exact p-values for the difference between the slopes for
WT and 3DG64S on HeLa (0.0129) and PVR-3T3 (0.0013) were derived from a mixed linear effects model (see
Methods). All plotted data can be found in SI, S1 Data. HeLa, human epithelial cells; PVR, poliovirus receptor; WT,
wild-type.
https://doi.org/10.1371/journal.pbio.2006459.g003
diversity in the inoculum was manipulated using exogenous mutagen—2 passages in ribavi-
rin and 5-fluorouracil followed by propagation in the absence of mutagen over 2 additional
passages. The diversity of the mutant spectrum was assessed by Sanger sequencing of the 5’
noncoding and capsid-coding regions of viruses from 24 plaques.
Given the difficulty in controlling the type and level of genetic diversity in a population
for correlative studies, we instead generated 5 independent stocks each of WT and
3DG64S and compared their diversity through next-generation sequencing. Using an
internally benchmarked analysis pipeline that dramatically reduces false positive variant
calls (see [47] and Methods), we identified no variants at greater than 0.1% frequency.
Therefore, we can exclude any significant differences in standing genetic diversity between
our WT and 3DG64S populations. Even at extremely high MOIs, variants present at <0.1%
are unlikely to complement each other or to cooperate reproducibly in a cellular context or
in vivo [48].
The absence of mutational diversity in our replicate WT and 3DG64S stocks is important
because poliovirus populations are subject to stringent bottleneck events, which further restrict
intrahost diversity [49–51]. Work with barcoded RNA viruses suggests that the serial bottle-
necks between the infecting population and the terminal population colonizing the central
nervous system (CNS) are quite stringent [52,53], and we used published data to quantify the
aggregate bottleneck size encountered by poliovirus in transgenic mice [46,49,50]. Maximum
likelihood optimization of a simple probabilistic model estimated an aggregate bottleneck size
of 2.67 between the inoculum and the CNS (Fig 4A, S1 Text Model 2). Therefore, the popula-
tion that causes eventual disease in these mice is derived from no more than 2 to 3 viruses in
the infecting population. In the setting of tight bottlenecks, many mutations will increase in
frequency due to genetic drift as opposed to positive selection.
We infected groups of PVR mice intramuscularly with both WT and 3DG64S populations.
Both viruses were able to access the CNS efficiently through this route over a range of doses
(Fig 4B, S2 Table), but there was a clear delay in the 3DG64S group (p = 0.0239, p< 0.001,
and p< 0.001 for 105, 106, and 107 pfu inocula, respectively). This lag persisted even
when we infected with doses 20-fold higher than the median lethal dose (LD50) of 3D
G64S
(S3 Table). The difference in 3DG64S attenuation compared to prior work [7] does not
appear to be due to the mouse model used because other studies in cPVR mice have
reported results similar to those presented here [36,54]. Both viruses spread to the CNS and
replicated to high titers after intravenous inoculation, although WT titers in the brain and
spinal cord were marginally higher at 5 days post infection (Fig 4C, p = 0.0012 for brain and
p = 0.0221 for spinal cord, Mann Whitney U test). We characterized the mutations present
in the CNS populations of 12 spinal cords of intravenously infected mice (Fig 4D, 7 WT and
5 3DG64S). Most mutations were rare, none were shared among mice, and there was an
excess of synonymous or noncoding variants relative to nonsynonymous ones. These data
are consistent with random sampling of the infecting population as opposed to positive
selection.
We also examined the impact of the r-selected mutations on virulence. The 2CV127L muta-
tion, which conferred a fitness of 1.11 in the 3DG64S background and does not appear to affect
fidelity (S3 Fig), restored virulence to nearly WT levels (p = 0.0012, log rank test; compare
3DG64S to 3DG64S;2CV127L in Fig 4E). In contrast, the triple mutant, 3DG64S;I92T;K276R—which
replicates with a WT mutation rate and a marginally increased fitness of 0.7637—was only
slightly more virulent than the high-fidelity variant 3DG64S (p = 0.0411, log rank test; compare
3DG64S to 3DG64S;I92T;K276R in Fig 4F). Therefore, restoration of replicative speed restored viru-
lence in 3DG64S, but compensation of the fidelity phenotype did not.
Discussion
We used a well-studied antimutator variant of poliovirus to identify the selective forces that
optimize a pathogen’s mutation rate. Using 3 different assays, we identified a significant fitness
cost to higher fidelity and directly link this cost to viral replication kinetics. Our quantitative
model of the speed–fidelity trade-off suggests that selection for replicative speed has pushed
viral mutation rates to a level that imposes a significant fitness cost at baseline due to lethal
or highly deleterious mutations. Consistent with the trade-off model, direct selection for
increased replicative speed led to indirect selection of polymerases with higher mutation rates.
The genetic interactions are quite strong because the 2 compensatory mutations exhibited
reciprocal sign epistasis. The speed–fidelity trade-off in the poliovirus RdRp appears to be a
generalizable phenomenon because compensatory mutations that increased the replicative
speed of the 3DK359H antimutator also increased its mutation rate (Table 1). Given the struc-
tural similarity among viral RdRp, the polymerases of other RNA viruses are likely to be sub-
ject to the same speed–fidelity trade-off, and we predict that the molecular mechanisms
governing polymerase kinetics and mutation rate will be similar.
Fig 4. In vivo phenotype of WT and 3DG64S. (A) Maximum likelihood optimization of a simple binomial model (see S1 Text Model 2) estimated an
average inoculum to CNS bottleneck size of 2.67 (lambda 2.44; 95% CI 1.39–3.82) based on experimental data for 4 barcoded poliovirus populations [49].
Shown are outputs of 10,000 simulations of the model (number of mice with 1, 2, 3, or 4 barcodes represented in the CNS). Each simulation represents 27
mice, and each mouse has a bottleneck size drawn from a zero-truncated Poisson with an average lambda of 2.43 (blue) or 10 (magenta). Line is actual data
from [49], the shaded regions represent the area occupied by 95% of the simulations, and the dark shaded regions represent the interquartile range of the
simulations. (B) Survival curves showing mice with paralysis-free survival over time for groups infected intramuscularly with 105 pfu (left; n = 12 per virus),
106 pfu (center; n = 18 per virus), and 107 pfu (right; n = 18 per virus) of WT (black) or 3DG64S (dashed blue). p< 0.05; p< 0.001 by log rank test. (C)
Viral titer in brain and spinal cord 5 days post intravenous inoculation with 107 pfu of WT (filled circles) or 3DG64S (open circles). p< 0.05; p< 0.005 by
Mann Whitney U test; n = 7 mice in each group (out of 8 that were infected, 1 mouse in each group had titers below the limit of detection, dotted line). (D)
Histogram of frequencies of intrahost SNVs identified in the spinal cords of 12 mice from panel C (7 infected with WT and 5 infected with 3DG64S). Black,
synonymous or noncoding; blue, nonsynonymous. (E) Survival curves showing mice with paralysis-free survival over time for groups (n = 43 per virus
combined from 2 experiments) infected intramuscularly with 106 pfu of 3DG64S (dashed blue) or 3DG64S;2CV127L (orange). p< 0.005 by log rank test;
actual p-value 0.0012. (F) Survival curves showing mice with paralysis-free survival over time for groups (n = 43 per virus combined from 2 experiments)
infected intramuscularly with 106 pfu of 3DG64S (dashed blue) or 3DG64S;I92T;K276R (pink). p< 0.05 by log rank test; actual p-value 0.0411. All plotted data
can be found in S1 Data. CNS, central nervous system; SNV, single-nucleotide variant; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2006459.g004
Trade-offs are essentially constraints that force one parameter to change with another. In
this case, viral mutation rate changes with replicative speed [55]. Similar trade-offs are central
to the kinetic proofreading hypothesis, which posits a close relationship between the error
rates of biosynthetic processes and the kinetics of their component reactions [56]. Studies of
DNA replication and protein translation suggest that these systems optimize speed over accu-
racy as long as the error rates are within a tolerable range [57,58]. We find a similar phenome-
non in viral RdRp, in which the WT generates an extraordinary amount of mutational load,
largely because of the benefit in replicative speed.
Failure to consider evolutionary trade-offs can lead to teleological errors, in which the con-
sequences of a process (e.g., increased genetic diversity) are misinterpreted as a cause (e.g.,
direct selection for a higher mutation rate [19,23,26]). Similarly, we find that the proposed link
between within-host genetic diversity and virulence is confounded by the fact that faster repli-
cating viruses are both more virulent and have higher mutation rates. The high mutation rates
of RNA viruses and the highly deleterious fitness effects of mutations ensure that most genetic
diversity is extremely rare and unlikely to be consistently maintained in the face of intrahost
and interhost bottlenecks [53]. We do not dispute that virus populations will harbor minority
variants, that a subset of these mutations may be adaptive or beneficial to the virus, and that
some may be virulence determinants. However, the observation of genetic diversity is not in
and of itself evidence that selection has optimized mutation rates for the future benefit of novel
mutations. Indeed, our data show little adaptive benefit to a marginally increased mutation
rate and identify no plausible mechanism whereby the observed increase in rare genetic diver-
sity can influence pathogenesis. We suspect that RNA viruses are subject to other trade-offs of
evolutionary significance, perhaps between polymerase speed and recombination rate or
between recombination rate and polymerase fidelity. Here too it will be important to define
the selective forces at play, thereby separating the causes from the consequences.
Methods
Ethics statement
The University of Michigan Institutional Animal Care and Use Committee reviewed and
approved the protocols for all mouse studies described in this manuscript (Protocol ID
PRO00008088). The University’s Animal Welfare Assurance Number on file with the NIH
Office of Laboratory Animal Welfare (OLAW) is A3114-01. Information on humane end-
points used, the length of each experiment, the numbers of animals used and subsequently
euthanized (S2 and S3 Tables), the frequency of monitoring, and animal welfare consider-
ations are described below (“Infection of transgenic mice” section).
Cells and viruses
A low passage stock of HeLa cells (<2 weeks in culture), previously obtained directly from
ATCC (CCL-2), was kindly provided by Mary O’Riordan (University of Michigan). Except
where noted, these cells were used for all experiments in this study and maintained in minimal
essential media (MEM; Invitrogen 11090), supplemented with 10% fetal bovine serum (Gibco
or Hyclone), 1x penicillin-streptomycin (Invitrogen 15140–148), 1x sodium pyruvate (Invitro-
gen 11360), 1x MEM alpha nonessential amino acids (Invitrogen 11140), and 1x glutamine
(Invitrogen 25030). A second stock of HeLa of unknown passage history was obtained from
Michael Imperiale (University of Michigan). These cells were only used for plaque assays to
titer stocks and were maintained in Dulbecco’s modified Eagle’s media (DMEM; Invitrogen
11965) supplemented with 10% fetal bovine serum and 1x penicillin-streptomycin. PVR-3T3
cells are described below and were maintained in DMEM supplemented with 10% fetal bovine
serum, 1x penicillin-streptomycin, and 1x glutamine. In all cases, cell lines were maintained
for no more than 30 passages at a time. WT poliovirus and all mutants were generated from
plasmid pEW-M, a Mahoney clone originally obtained from Eckard Wimmer (SUNY-Stony-
brook) [59].
Generation of PVR-3T3 cells
C57/BL6 PVR-Tg21 (PVR) mice [45,46] were obtained from S. Koike (Tokyo, Japan) via Julie
Pfeiffer (UT Southwestern) and maintained in specific pathogen-free conditions. Primary
MEFs were derived from PVR mice. Day 13.5 embryos were harvested and washed in phos-
phate-buffered saline (PBS). The heads and viscera were removed, and the body was minced
with a sterile razor blade, trypsinized, and homogenized by pipetting with a 10 ml serological
pipette. Cells were plated in DMEM supplemented with 10% fetal bovine serum, 1x penicillin-
streptomycin, and 1x glutamine. An immortalized cell line was derived from PVR MEFs fol-
lowing the 3T3 protocol [60]. Briefly, freshly thawed MEFs were plated in 30 T25 flasks at a
density of 3.8 × 105 cells per flask in complete DMEM. Every third day, cells in each flask were
trypsinized, counted, and transferred to fresh flasks at a density of 3.8 × 105 cells per flask. As
the cellular population began to increase (passages 13–15), cells were expanded into larger ves-
sels and ultimately frozen down at passage 17.
Site-directed mutagenesis
All mutations were introduced into either pEW-M or subclones using overlap extension PCR
[61]. The presence of the desired mutation and the absence of additional mutations were veri-
fied by Sanger sequencing of the amplified insert and, in some cases, the entire genome.
In vitro transcription, transfection, and viral stocks
Viral RNA was generated by in vitro transcription of the corresponding plasmid clone using
T7 RNA polymerase, and virus was recovered following RNA transfection of HeLa. For trans-
fections, 2.6 × 105 HeLa were plated per well in a 12-well plate the day prior. One microgram
of RNA was mixed with 4 μl TransIT mRNA transfection reagent (Mirus 2225) and 100 μl
OptiMEM (Invitrogen 31985), incubated according to the manufacturer’s protocol and
applied to cells. Passage 0 virus was harvested at 100% CPE (within 24–48 hours). Passage 1
stocks were generated by passaging 100 μl of passage 0 virus on fresh cells and were titered by
either plaque assay or TCID50. Passage 2 and 3 stocks were generated by passaging at an MOI
of 0.01. For all stocks, cells were subjected to 3 freeze–thaw cycles and the supernatants clari-
fied by centrifugation a 1,400 × g for 4 minutes. These supernatants were stored at −80 ˚C in
aliquots to limit the number of subsequent freeze–thaw cycles.
Competition assay for viral fitness
Competition assays were performed essentially as described in [17,42]. For the experiment in
Fig 1A, HeLa cells were plated in 12-well plates, at a density of 2.6 × 105 per well the day prior
to infection. Cells were infected at a total MOI of 0.1 with an equal TCID50 of WT and 3D
G64S.
Three replicate wells were infected with each pair of viruses in 250 μl for 1 hour with occa-
sional rocking. After 1 hour, the inoculum was removed and 1 ml fresh media applied. Passage
1 virus was harvested after an additional 7 hours (8 hours since infection). The titer of the pas-
sage 1 virus was used to calculate the dilution factor necessary to maintain an MOI of 0.1 for
the subsequent 5 passages. RNA was harvested from each passage using Trizol (Ambion
15596026). Random hexamers were used to prime cDNA synthesis with 1/10 of the RNA.
Each cDNA was analyzed by qRT-PCR using 3 different primer and/or probe sets with dupli-
cate PCR reactions for each sample and primer set. The first set—COM2F 5’ CATGGCAGCC
CCGGAACAGG 3’‘ and COM2R 5’ TGTGATGGATCCGGGGGTAGCG 3’—was used to
quantify total viral genomic RNA in an SYBR green reaction (Power SYBR Green PCR Master
Mix; Thermo 4368708). Two custom TaqMan probes (Applied Biosystems) were used to quan-
tify the number of WT and 3DG64S genomes. Duplicate wells were averaged, and relative
amounts of WT and 3DG64S RNA were determined by normalizing the cycle thresholds for
each of these probes to those of the COM primer set (ΔCt = CtVirus − CtCOM). The normalized
values for virus passages 1–6 were then compared to passage 0 to obtain a ratio relative to P0
(ΔΔCt = ΔCtPX − ΔCtP0). This relative Ct value was converted to reflect the fold change in the
ratio (Δratio = 2−ΔΔCt). The change in ratio of the mutant relative to the change in ratio of the
WT as a function of passage is the fitness ([Δlog ratioMut − Δlog ratioWT]/time). Competition
assays in ribavirin (Fig 1F) were performed in the exact same manner except that serum-free
media were used in both drug and mock passages.
For all other competition assays (Fig 3), we compared the experimental virus (e.g., WT P4,
3DG64S P8, etc.) to a tagged WT reference (Tag8). We plated 2.6 × 105 cells per well (either
HeLa or PVR-3T3) in 12-well plates. Infections were performed at an MOI of 0.05 in 250 μl
complete media for 1 hour. After an hour, the media were aspirated and fresh 1 ml growth
media applied. All passages were for 24 hours. The dilution factor between passages required
to maintain this MOI was 400 for HeLa competitions and 350 for PVR-3T3 competitions. All
RNA harvests for these competitions were performed in 96-well plates using Purelink Pro 96
Viral RNA/DNA kits (Invitrogen 12280), and cDNA synthesis was performed as above. In
addition to the COM primer set (see above), we used primer pairs Tag8 seq.tag 5’ TTCAGCG
TCAGGTTGTTGA 3’ + Rev. WT seq.tag 5’ CAGTGTTTGGGAGAGCGTCT 3’ and WT seq.
tag 5’ AGCGTGCGCTTGTTGCGA 3’ + Rev. WT seq.tag 5’ CAGTGTTTGGGAGAGCGTCT
3’ to quantify the Tag8 reference and test samples, respectively. Note also that in these compe-
titions the regressions were fit through passages 1–4 and excluded P0 as slight deviations from
a 1:1 ratio of the two viruses in the inoculum can skew the slope when fit through this data
point.
Plaque-size assay
Plaque assays were performed on subconfluent monolayers (7.5 × 106 on day of infection) in
10 cm dishes. The amount of virus applied to each plate was determined empirically to ensure
well-spaced plaques (approximately 30 per 10 cm dish). Plates were stained with crystal violet
at 72 hours post infection. Each plate was scanned individually at 300 dpi using a flat-bed scan-
ner. Sixteen-bit image files were analyzed using ImageJ. Brightness, contrast, and circularity
thresholds for plaque identification were set using uninfected plates.
Single replication cycle growth curve
The day prior to infection, 4 × 105 HeLa cells were plated in 12-well plates with 45 wells per
virus (9 time points and 5 replicates per time point). Cells were infected at an MOI of 1 in
150 μl volume, and the infections were synchronized by incubation on ice for 1 hour with
occasional rocking. At 1 hour, the inocula were aspirated, each well was washed twice with ice-
cold PBS, and 1 ml of fresh, prewarmed growth media were applied to all wells. One set of 5
wells was immediately frozen as the t = 0 hours time point. All other plates were returned to
the incubator, and a set of 5 wells was removed and frozen at t = 1.5, 2, 2.5, 3, 3.5, 4, 5, and 7
hours. All samples were titered by TCID50. The growth curve on PVR-3T3 cells was performed
using a similar protocol, except that 5 × 105 cells were plated the day prior and the time points
were t = 1, 2, 3, 4, 5, 6, 7, and 8 hours.
Measurement of viral mutation rates
Mutation rates were measured by Luria-Delbruck fluctuation test, which in this case quantifies
the rate at which the poliovirus 2C protein acquires the necessary point mutations to permit
viral growth in 1 mM guanidine hydrochloride [62–64]. Each fluctuation test was performed
with 29 replicate cultures in 48-well plates. A total of 65,000 HeLa cells per well were plated the
day prior to infection. In all cases, the media were changed to serum-free media 3 hours prior
to infection. For infections in ribavirin, this serum-free media also included drug at the speci-
fied concentrations. Each well was infected in 200 μl volume with 1,000 to 4,000 pfu per well
depending on the virus and experimental condition. Five independent aliquots were also saved
for subsequent titering (see Ni below). For infections in ribavirin, the infection media also
included drug at the specified concentrations. Infected cells were incubated for 7 hours and
then frozen. The lysed cells and media were harvested following 3 complete freeze–thaw cycles
and transferred to a microcentrifuge tube. The empty wells were rinsed with 300 μl of complete
growth media and combined with the initial 200 μl lysate. This 500 μl lysate was clarified by
centrifugation at 1,400 × g for 4 minutes. Twenty-four wells were titered by plaque assay with
1 mM guanidine hydrochloride in the overlay (see P0 below). Five wells were titered by stan-
dard plaque assay without guanidine hydrochloride (see Nf below). The mutation rate, μ0, was
estimated from these data using the P0 null-class model: μ0 = −lnP0/(Nf-Ni), where P0 was the
fraction of the cultures that yielded no guanidine-resistant plaques, Nf was the average number
of pfu in the absence of guanidine, and Ni was the average number of pfu in the inoculum. As
described in [65], μ0 can be converted to the mutation rate in nucleotide units by correcting
for the mutation target (number of mutations leading to the scored phenotype, T) and the
number of possible mutations at each target site (constant, 3) using the equation μ = 3μ0/T.
The number of distinct mutations that could yield the guanidine-resistant phenotype was
determined empirically by isolating and sequencing the entire 2C open reading frame for 15
guanidine-resistant plaques derived from WT virus and 15 guanidine-resistant plaques derived
from WT virus treated with 200 μM ribavirin. In each case, we found 6 mutations that medi-
ated resistance, although there were 7 total among 30 plaques (S1 Table).
Mutagen sensitivity assay
HeLa cells were plated the day prior to infection at a density of 2.6 × 105 cells per well in a
12-well dish. On the day of infection, monolayers were pretreated with 0 to 600 μM ribavirin
in serum-free media for 3 hours, then infected with virus at an MOI of 0.1 (50,000 pfu) for 60
minutes. The cells were washed once in PBS and incubated in ribavirin for an additional 24
hours. Viral supernatants were harvested by freeze–thaw as above and titered by tissue culture
infectious dose.
R-selection through serial passage
For each passage, HeLa cells were plated the day prior to infection in 6-well plates at a density
of 7.25 × 105 cells per well, yielding 1.2 × 106 cells on the day of infection. Infections were
initiated with passage 3 stocks of either WT or 3DG64S, and each passage was performed at an
MOI of 0.5 (6 × 105 TCID50 units) in 1 ml of media for 1 hour with occasional rocking. After 1
hour, the inoculum was aspirated, the cells were washed twice with PBS, and 2 ml of fresh
growth media were applied. For the first 15 passages, WT and 3DG64S viruses were harvested
at 4 and 4.5 hours, respectively. For passages 16 through 50, WT and 3DG64S viruses were
harvested at 3.5 and 4 hours, respectively. Control populations were infected in the same man-
ner except that viruses were harvested at 24 hours post infection. There were 5 r-selected WT
lineages, 5 r-selected 3DG64S lineages, 5 control WT lineages, and 5 control 3DG64S lineages.
Viruses were titered at every fifth passage to maintain an MOI of approximately 0.5.
Selection and identification of second-site suppressors of RdRp variant
3DK359H
HeLa cells were transfected by electroporation with viral RNA transcript, added to HeLa cell
monolayers, and incubated at 37 ˚C. After 2 days, the media were passaged onto a separate
monolayer of HeLa cells. Upon cytopathic effect, viruses were harvested by 3 repeated freeze–
thaw cycles, cell debris was removed by centrifugation, and viral supernatants were titrated. In
this time frame, the titer increased approximately 40-fold (from 5.1 × 105 pfu/mL to 2.1 × 107).
Viral RNA was isolated with QIAamp viral RNA purification kits (Qiagen) according to the
manufacturer’s instructions. The 3Dpol cDNA was prepared from purified viral RNA by
RT-PCR and sequenced. The I331F and P356S substitutions were identified together in 1
experiment, and the P356S substitution was identified in a second.
In vitro assays of RdRp function
All mutations were introduced into the pET26Ub-PV 3D [66] or pSUMO-PV-3D [67] bacte-
rial expression plasmids using either overlap extension PCR or QuickChange Site-Directed
Mutagenesis. The presence of the desired mutations and the absence of additional mutations
were verified by DNA sequencing. PV 3Dpol RdRps were expressed and purified as described
previously [66,67]. The sym-sub assays used to measure assembly and elongation kinetics of
purified RdRp on a defined template were performed as described in [6,30,68]. All assays had
1 μM primer/template and 2 μM enzyme.
Adaptability of WT and 3DG64S
For HeLa cells, adaptability was measured using the 24-hour passage control lineages from the
r-selection experiment. The fitness values of WT and 3DG64S populations were measured by
competition assay, as above, using samples from passages 0, 5, 10, 15, and 20. For PVR-3T3
cells, serial passages were performed as follows. Cells were seeded in 6-well plates at a density
of 7.6 × 105 cells per well the day prior to infection, yielding approximately 1 × 106 the day of
infection. Serial passage lineages were initiated with passage 1 stocks of either WT or 3DG64S,
and each passage was performed at an MOI of 0.5 in 1 ml for 1 hour. After 1 hour, the inocu-
lum was aspirated, the cells were washed twice with PBS, and 2 ml of fresh growth media were
applied. Viruses were harvested at 24 hours and titered every fourth passage to ensure an MOI
of 0.5. There were 5 replicate lineages of WT and 3DG64S.
Infection of transgenic mice
Six- to 9-week-old mice were used for all experiments. The age range and distribution of males
and females in each group for each experiment are reported in S2 Table. On the day of each
infection, a general health exam was performed on all animals by university veterinary techni-
cal staff, and animals were assigned unique ear tag identifiers. Study animals were housed in
BSL2 conditions. Females were housed together by group. Males from the same litter were
housed together and were separated by group as needed. Enrichment was provided when any
animal became single-housed due to fighting or other indication. Animals were fed 5LOD
rodent chow. Because hindlimb paralysis was an expected outcome of this study, moist chow
placed on floor of cage and/or diet gel was provided as a supplement. Water was provided ad
libitum. Temperature and humidity were monitored and recorded daily by husbandry staff on
general housing room sheets. Alternating 12-hour light and dark cycles were in place as per
standard housing.
For survival analyses, mice were infected intramuscularly with 50 μl to each hindlimb for
the total dose of 100 μl. Mice were observed twice daily for lethargy, hunched posture, scruffy
fur, paralysis, or decreased mobility and were euthanized when they exhibited bilateral hin-
dlimb paralysis. Over 90% of all assessments were performed by members of the university vet-
erinary technical staff, who were blinded to the hypotheses and expected outcomes of the
studies. All surviving animals were euthanized after 12 days. These endpoints were also used to
calculate the PD50 using the Spearman-Karber method (S3 Table).
For tissue distribution analyses, mice were infected intravenously via tail vein with 100 μl
and observed twice daily as above. Mice were euthanized for severe morbidity (as above) or
on day 5, the conclusion of the experiment. Whole organs were isolated from all mice and
homogenized in PBS using a Bead Beater. The homogenates were clarified by centrifugation at
15,800 × g for 4 minutes in a microfuge and the supernatant extracted with chloroform. Half of
this supernatant was titered by TCID50. RNA was extracted from the remainder using Trizol.
Next-generation sequencing
We amplified poliovirus genomes as 4 overlapping cDNA by RT-PCR. RNA was harvested
from either cell-free supernatants or tissues as above and was reverse-transcribed using the
SuperScript III First Strand Synthesis System for RT-PCR (Invitrogen 18080) and a mixture of
random hexamers and oligo dT primer. The 4 genomic fragments were amplified using primer
pairs: WFP37 FORWARD BASE 1 5’ TTAAAACAGCTCTGGGGTTGTACC 3’ + WFP41
REVERSE BASE 2434 5’ GCGCACGCTGAAGTCATTACACG 3’; WFP39 FORWARD
BASE. 1911 5’ TCGACACCATGATTCCCTTTGACT 3’ + WFP42 REVERSE BASE 4348 5’
AATTTCCTGGTGTTCCTGACTA 3’; WFP13 FORWARD BASE 4087 5’ ATGCGATGTTCT
GGAGATACCTTA 3’ + WFP43 REVERSE BASE 5954 5’ CCGCTGCAAACCCGTGTGA 3’;
WFP40 FORWARD BASE 5545 5’ TTTACCAACCCACGCTTCACCTG 3’ + WFP33
REVERSE BASE 7441 5’ CTCCGAATTAAAGAAAAATTTACCCC 3’. The thermocycler pro-
tocol was 98 ˚C for 30 seconds, then 30 cycles of 98 ˚C for 10 seconds, 68 ˚C for 20 seconds,
and 72 ˚C for 3 minutes, followed by a single cycle of 72 ˚C for 5 minutes, then 4 ˚C hold. For
each sample, amplification of all 4 fragments was confirmed by gel electrophoresis, and equal
quantities of each PCR product were pooled. Seven hundred and fifty nanograms of each
cDNA mixture were sheared to an average size of 300 to 400 bp using a Covaris S220 focused
ultrasonicator. Sequencing libraries were prepared using the NEBNext Ultra DNA library prep
kit (NEB E7370L), Agencourt AMPure XP beads (Beckman Coulter A63881), and NEBNext
multiplex oligonucleotides for Illumina (NEB E7600S). The final concentration of each bar-
coded library was determined by Quanti PicoGreen dsDNA quantification (ThermoFisher Sci-
entific), and equal nanomolar concentrations were pooled. Residual primer dimers were
removed by gel isolation of a 300 to 500 bp band, which was purified using a GeneJet Gel
Extraction Kit (ThermoFisher Scientific). Purified library pools were sequenced on an Illu-
mina MiSeq with 2 × 250 nucleotide paired-end reads. All raw sequence data have been depos-
ited at the NCBI short-read archive (Bioproject PRJNA396051, SRP113717).
Variant detection
Sequencing reads that passed standard Illumina quality-control filters were binned by index
and aligned to the reference genome using bowtie [69]. SNVs were identified and analyzed
using DeepSNV [70], which relies on a clonal control to estimate the local error rate within a
given sequence context and to identify strand bias in base calling. The clonal control was a
library prepared in an identical fashion from the pEW-M plasmid and was sequenced in the
same flow cell to control for batch effects. True positive SNVs were identified from the raw
output tables by applying the following filtering criteria in R: (i) Bonferonni-corrected
p< 0.01, (ii) average MapQ score on variant reads>20, (iii) average phred score on variant
positions >35, (iv) average position of variant call on a read>62 and<188, and (v) variant
frequency>0.001. We only considered SNVs identified in a single RT-PCR reaction and
sequencing library for samples with copy number105 genomes/μl supernatant or in 2 sepa-
rate RT-PCR reactions and sequencing libraries for samples with copy number 103 to 105
genomes per μl (e.g., in tissue studies). Our strategy for variant calling as well as our bench-
marked sensitivity and specificity are described in [47], and all code can be found at https://
github.com/lauringlab/variant_pipeline.
Statistical analysis
No explicit power analyses were used in designing the experiments. In most cases, we used 5
biological replicates. In a few cases, we used fewer (3) or more (7) where the variance was
either sufficiently low or high. The number of replicates, the statistical tests used, and the rele-
vant p-values are reported in each figure legend or the main text (Fig 2C and 2D only). All rep-
licates within the dynamic range of each assay are reported (i.e., no replicate experiments were
excluded). Data on the relative adaptability of WT and 3DG64S populations were analyzed with
a 3-level linear mixed-effects model estimating a random slope and intercept of time nested
within each fitness measurement replicate (measID), nested within each lineage replicate
(repID). Virus was included as a fixed effect. Models were fit with the R package lme4; all code
for this model can be found at https://github.com/lauringlab/speed_fidelity.
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